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Abstract
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Congenitally corrected transposition of the great arteries (CCTGA) is a rare
congenital heart disease that commonly results in congestive heart failure due to
exposure of the anatomic right ventricle to systemic pressures. Additional
anatomic abnormalities, such as situs inversus, in which the viscera are mirror
images of normal anatomy, or dextrocardia in which the heart apex is located on
the patient’s right, once were contraindications to transplant in the treatment of
advanced heart failure. However, recent advancements now allow for the
management of heart failure through mechanical circulatory support and
subsequent transplant. This case presents a 52 year-old man with advanced
heart failure secondary to CCTGA and dextrocardia situs inversalis totalis that
was managed with a ventricular assist device (VAD) after maximal medical
treatment, and subsequently received an orthotopic heart transplant. This case
will also review CCTGA in relation to heart failure and the surgical challenges
faced in terms of ventricular assist device implantation and orthotopic heart
transplant.
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Introduction
Congenitally corrected transposition of the great arteries (CCTGA), or LevoTransposition of the Great Arteries (L-TGA) is a rare form of congenital heart
disease that results from abnormal leftward looping of the primitive heart tube
yielding reversal of the ventricles. Patients with this condition exhibit both
atrioventricular and ventriculoarterial discordance. As an isolated condition,
patients are asymptomatic during early life. Nearly 90% of cases are associated
with additional cardiac abnormalities, which may account for any early symptoms
observed.1 The most common of these conditions are ventricular septal defects,
pulmonary outflow obstructions, as well as tricuspid and mitral valve
abnormalities.
Dextrocardia can be an isolated occurrence, but is commonly associated with
situs inversus totalis.2 Typically, this condition is asymptomatic, although it may
be associated with occurrence of congenital conditions such as Kartagener’s
Syndrome (Primary Ciliary Dyskinesia), congenital transposition of the great
arteries, and various other conditions, all in varying combinations.3 In the case of
NYHA stage IV Heart Failure in these patients, situs inversus totalis was once
considered a contraindication to mechanical circulatory support and heart
transplantation.. However, recent advancements have made it possible to
overcome this limitation.4 Special considerations may include anastomosis of
donor and recipient IVC and creation of a conduit out of the recipient’s right
atrium.2-7 Prior to heart transplantion in this patient population, correction of
extracardiac congenital conditions may be required.8
Many patients with CCTGA and situs inversus develop congestive heart failure
(CHF) later in life. In these patients, mechanical circulatory support is one option,
which presents increased technical difficulty with respect to surgical intervention.
Southard et al have described one such case of ventricular assist device (VAD)
placement in a patient with both dextrocardia and CCTGA.9 Other cases have
been reported in the literature regarding VAD placement or transplantation in
either of these two conditions.8,10,11 We present a case of systemic VAD
placement in a patient with CCTGA and dextrocardia situs inversus to address
the challenges of heart failure management in this particular patient population.

Clinical Summary
A 52 year-old man with a known history of CCTGA and dextrocardia situs
inversus totalis presented in January 2013 with worsening shortness of breath,
dyspnea on exertion, and lower extremity edema. Ejection fraction was 15%. His
past medical history was significant for chronic atrial flutter, deep vein and atrial
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thromboses, chronic kidney disease, and pulmonary hypertension. Outpatient
medical management consisted of a beta blocker, angiotensin receptor blocker,
loop diuretic, digoxin, and sildenafil.
He was in atrial fibrillation on admission. After optimization of hemodynamics
with milrinone 0.5 mcg/kg/min and diuresis, catheterization demonstrated right
atrial pressure 7mmHg, pulmonary artery pressure 48/26 with a mean of
34mmHg and pulmonary capillary wedge pressure 9mmHg. Cardiac index
remained reduced at1.89 L/min/m2 by thermodilution and 1.78 L/min/m2 by
Fick’s method. Pulmonary vascular resistance was 6.6 Wood units. Coronary
arteries were normal. It was determined that pulmonary ventricular function
(morphological LV) was sufficient to allow use of a systemic ventricular assist
device.
Transesophageal echocardiography (TEE) demonstrated biventricular systolic
failure with an ejection fraction (EF) of 15%, severe regurgitation of the systemic
atrioventricular valve (morphologic tricuspid valve) with a markedly dilated
systemic atrium. A small membranous VSD with continuous flow was noted.
Flow was not measured.
Despite optimal medical management, the patient was admitted with rapidly
deteriorating NYHA Class IV, Stage D heart failure and was subsequently
evaluated by an interdisciplinary team for the placement of a VAD. A cardiac
MRI (Fig. 1) confirmed atrial and visceral situs inversus with L-transposition,
biventricular hypokinesis with severe dilation of the systemic ventricle (systemic
ejection fraction 23%), systemic atrio-ventricular valvular insufficiency, and
pulmonary artery dilation to 5.7cm. The anatomy of the pulmonary veins and
systemic thoracic veins was conventional. Based on hemodynamic and
anatomic data, he was referred for mechanical circulatory support.
Implantation of the HeartWare HVAD ventricular assist device was performed
through a median sternotomy. The patient’s anatomy was identified carefully,
with the superior vena cava (SVC) and inferior vena cava (IVC) clearly on the left
side, and the systemic ventricle was obviously a morphologic right ventricle. The
aorta and the pulmonary artery were relatively normally oriented, although the
pulmonary artery was quite large, consistent with known pulmonary
hypertension. An appropriate site on the ventricular free wall towards the right
side of the left anterior descending coronary artery was identified. The HVAD
ring was placed on the lateral side of the apex of the systemic (morphologic right)
ventricle to approximate the permanent position of the VAD, allowing for stitches
to be placed through the ventricular wall and the VAD ring. The outflow graft was
anatamosed to the ascending aorta. Upon removal of the ventricular core, a
papillary muscle had been injured, leading to a flail systemic atrioventricular
valve leaflet. This was confirmed by intraoperative TEE, and the valve was
replaced with a 31 mm pericardial tissue valve by approaching the mitral valve
through the dome of the left atrium. The patient was successfully weaned from
cardiopulmonary bypass with excellent VAD function (Fig 2).
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Figure 1. Preoperative MRI revealing dextrocardia and cardiomegaly (A),
marked dilation of the pulmonary trunk (B), and situs inversus totalis (C).

Figure 2. Postoperative chest x-ray showing right-sided placement of VAD
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While recovering in the ICU, the patient was weaned from pressors and placed
on sildenafil. Post op day 1, the patient developed complete atrioventricular
block and a dual-chamber implantable cardioverter-defibrillator was implanted on
post-operative day 2. The patient was extubated on post-operative day 9.
Catheterization on post-operative day 22 showed excellent flow and filling
pressures, with improved cardiac index (2.53 L/min/m2 by thermodilution, and
3.51 by Fick’s method) and improvement of pulmonary hypertension (3.3 Wood
units by thermodilution, 2.1 Wood units by Fick’s method). Post-operative
complications included a transient ischemic attack of right sided weakness that
resolved right before discharge on post-operative day 28. The patient was found
to have aspirin resistance via thromboelastogram, and he was placed on
clopidogrel 75mg.
With the exception of difficulties related to anticoagulation that resulted in a
subarachnoid hemorrhage without residual deficits, the patient was relatively
stable with outpatient VAD management until a donor heart was located.
In May 2014, 1 year and 5 months after VAD placement, a suitable donor heart
became available and the patient underwent successful orthotopic heart
transplantation. Redo median sternotomy was performed, significant scar tissue
within the mediastinum was dissected carefully. The patient was heparinized
and cannulated. Cardiopulmonary bypass was initiated, the aorta was crossclamped and the heart with its accompanying VAD was fully excised. The leftsided SVC was addressed by using a 16mm externally supported Gore-Tex graft,
directed left to right across the diaphragm. Once the left atrium was
anastomosed to the left atrial cuff, the IVC graft was anastomosed to the donor
IVC. The recipient pulmonary artery was much larger in diameter than the donor
pulmonary artery, requiring complex reconstruction with a bovine pericardial
patch. To perform the SVC anastomosis, it was clear that the donor innominate
vein did not have enough length to reach the recipient SVC, so a 10mm graft was
placed. The patient was weaned successfully from cardiopulmonary bypass.
The chest was left open as hemostasis was not adequate for closure and the
patient was returned to the ICU. However, over the next two days, the patient
developed plethora of the face and neck. The patient was returned to the OR,
and a 13mm graft was placed between the recipient SVC and the donor SVC,
and the 10mm graft was revised to connect the recipient innominate vein and the
ligated donor jugular vein. (Fig. 3, 4). All grafts were reconstructed without
interrupting venous return from the upper body. The chest was closed on postoperative day 5.
The postoperative course involved multiple arrhythmias treated with amiodarone,
serratia bacteremia, acute kidney injury, thrombocytopenia, prolonged ventilation,
pleural effusion requiring thoracentesis, and CO2 retention. As the left ventricle
is directly under the sternum, echocardiographic assessment is difficult. Serial
measurements of left ventricular function have been made with radionucleotide
ventriculography. After a prolonged hospitalization and inpatient rehabilitation,
he had remained well with normal functional capacity. Left ventricular function
has remained normal, now 18 months after transplantation.
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Figure 3. Illustration demonstrating placement of the 10mm (red arrow)
recipient innominate vein to donor right jugular vein graft and 13mm (blue
arrow) recipient SVC to donor SVC graft, and the 16mm (yellow arrow) IVC
graft.

A

B
Figure 4. Postoperative computed tomography scan showing the 10mm (red
arrow) recipient innominate vein to donor right jugular vein graft and 13mm
(blue arrow) recipient SVC to donor SVC graft (A), and the 16mm (yellow arrow)
IVC graft (B).
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Discussion
CCTGA is a rare congenital anomaly occurring less than 0.5% of patients with
clinically evident congenital heart disease. CCTGA presents as an
atrioventricular discordance and ventriculoarterial discordance. Among these
individuals, 67% with severe associated anomalies and 25% of patients with
minor or no associated lesions will develop heart failure by age 45.1 The double
discordance in CCTGA results in a physiologic circulation, and unless there are
symptomatic associated anomalies, patients with CCTGA may remain
undiagnosed until the 4th or 5th decade, at which time they present often with
heart failure. Physiologically, the long term overload of a morphologic RV
supplying the systemic circulation, in combination with progressive AV valve
dysfunction and arrhythmia, overcomes any compensatory hypertrophy and
results in failure of the systemic ventricle. Subsequently, this can lead to
pulmonary hypertension, and eventual biventricular failure. Therefore, the timing
of referral for operative interventions in these patients is the major predictor of
outcome in CCTGA.12 For patients presenting with ventricular failure, options for
intervention may include inotropic support, valve repair, pulmonary banding,
anatomic repair via the “double switch” procedure, mechanical circulatory
support, and ultimately cardiac transplantation. Although these patients are
already high risk due to anatomical considerations and technical difficulty,
mechanical circulatory support in patients with CCTGA is a feasible and viable
option for patients either as a destination therapy or while awaiting
transplantation.
Until recently, mechanical circulatory support was difficult in these patients, even
without the concomitant presence of dextrocardia and situs inversus, which is
evident by the fact that there have been very few cases of placement of a VAD in
patients with CCTGA in the literature.10,11,13 Additionally, there have been few
cases of VAD placement in patients with either situs inversus or dextrocardia.
Based on prior case reports and through our experience with this particular
patient, it is evident that adjustments have to be made to ensure proper flow
through the VAD as these devices were designed to reside in the wall of a
morphologic left ventricle. In contrast to the near conical shape of the left
ventricle, the right ventricle is more triangular in shape, with possible inflow
obstructions such as an additional papillary muscle with accompanying chordae,
trabeculations, and the moderator band. Using TEE guidance, these must be
considered when determining placement of the VAD to prevent inflow
obstruction. With the introduction of smaller devices, placement of VADs in this
particular patient population will become more straightforward. The HeartWare
HVAD has a displacement volume of 50 cc. and is intended to be implanted in
the pericardial space. The outflow graft has a strain relief design that allows for
flexible implantation in patients with varied anatomy.
Orthotopic heart transplantation into a space formerly configured to a
dextrocardic situs inversus heart presents unique challenges. The main
challenge is to reconstruct the systemic venous return pathways to
accommodate a normally configured heart. This was first described in a case of
heart-lung transplantation by Miralles et al, in which a large single atrium was
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created to allow for venous anastomoses.14 This had its own limitations, such as
acting as point of stasis and possible thrombus formation, apart from its other
physiological implications. An alternative, similar to the technique used in our
case, was described in Deuse et al, consisting of a bi-caval technique with graft
interposition depending on the length of the donor innominate vein available.4 As
evidenced by the SVC syndrome requiring graft revision encountered
postoperatively in our case, special attention must be given to ensure that there
is adequate venous return.
In conclusion, we report a case of successful HeartWare HVAD placement with
subsequent orthotopic heart transplantation in a patient with CCTGA and
dextrocardia situs inversus.
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